Delivery Order SPE2DB22D1106-SPE2DB24FFJJ5

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of 4,563,348,558 units of Escitalopram 10 mg tablets. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $7,930.96, and a completion date of January 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4,566,307,044 units of the drug Escitalopram 10 mg tablet. The $1,409.47 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The contract has an ultimate completion date of November 4, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,239.69 firm fixed price delivery order is for the supply of 4,565,548,532 units of the pharmaceutical drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of August 23, 2024 and was awarded on August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,034 units of the drug Escitalopram 10 mg tablets. The contract has a ceiling value of $6,074.93 and a completion date of February 24, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,153,994 units of the prescription drug Escitalopram 10 mg tablets. The fixed-price contract has a ceiling value of $9,177.66 and a completion date of December 21, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,562,474,640 units of Escitalopram 10 mg tablets. The contract, valued at $4,633.42, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2023. The contract is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.38, is a delivery order for 4,562,280,822 units of the drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,461.02 firm fixed-price contract is for the delivery of 4,562,019,744 units of the prescription drug Escitalopram 10 mg tablet. The contract has an ultimate completion date of September 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 1,000 units of the medication Escitalopram 10 mg tablet, with a potential value of $2,836.32 and a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,748.20 firm fixed-price delivery order is for the supply of 4,563,865,533 units of the prescription medication escitalopram 20 mg tablet. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFJJ5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,565,095 units of the prescription drug escitalopram 10mg tablets. The delivery order, valued at $5,737.94, is a firm fixed-price contract with an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of medical commodities and pharmaceutical products from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract is not designated as a set-aside.

Generated 11/22/24, 9:48 AM